China Sentences Gene-Editing Scientist to Three Years in Jail

The modification of three babies’ genes by He Jiankui drew widespread criticism from scientists.

Written byEmily Makowski
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: WIKIMEDIA COMMONS, THE HE LAB

Update (April 5, 2022): He Jiankui has been released from prison, Technology Review reports.

He Jiankui, a former researcher at Southern University of Science and Technology in Shenzhen, China, who claimed to have created the world’s first gene-edited babies, was sentenced to three years in prison today (December 30) by a Chinese court for illegally practicing medicine. He was also fined 3 million yuan ($430,000 US). Two scientists who collaborated with He on the research, Zhang Renli and Qin Jinzhou, were given lesser sentences. All three pleaded guilty to the charges, reports The Associated Press.

“The three accused did not have the proper certification to practice medicine, and in seeking fame and wealth, deliberately violated national regulations in scientific research and medical treatment,” said the court, according to Reuters.

In November 2018, He announced the birth of twin girls with edited genes, leading to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies